The price of Atossa Therapeutics Inc (NASDAQ: ATOS) closed at $0.82 in the last session, down -2.71% from day before closing price of $0.84. In other words, the price has decreased by -$2.71 from its previous closing price. On the day, 0.81 million shares were traded. ATOS stock price reached its highest trading level at $0.85 during the session, while it also had its lowest trading level at $0.8113.
Ratios:
We take a closer look at ATOS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 12.67 and its Current Ratio is at 12.67. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on January 26, 2018, initiated with a Buy rating and assigned the stock a target price of $2.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 21 ’25 when QUAY STEVEN C bought 11,239 shares for $0.88 per share. The transaction valued at 9,887 led to the insider holds 13,898 shares of the business.
Remmel H. Lawrence bought 10,000 shares of ATOS for $7,000 on Mar 26 ’25. The Director now owns 10,257 shares after completing the transaction at $0.70 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATOS now has a Market Capitalization of 105544808 and an Enterprise Value of 40428812.
Stock Price History:
The Beta on a monthly basis for ATOS is 0.92, which has changed by -0.40145987 over the last 52 weeks, in comparison to a change of 0.17535925 over the same period for the S&P500. Over the past 52 weeks, ATOS has reached a high of $1.66, while it has fallen to a 52-week low of $0.55. The 50-Day Moving Average of the stock is -5.38%, while the 200-Day Moving Average is calculated to be -14.24%.
Shares Statistics:
According to the various share statistics, ATOS traded on average about 969.90K shares per day over the past 3-months and 668450 shares per day over the past 10 days. A total of 129.17M shares are outstanding, with a floating share count of 129.12M. Insiders hold about 0.04% of the company’s shares, while institutions hold 26.52% stake in the company. Shares short for ATOS as of 1752537600 were 4085861 with a Short Ratio of 4.21, compared to 1749772800 on 7415914. Therefore, it implies a Short% of Shares Outstanding of 4085861 and a Short% of Float of 3.1600002000000003.
Earnings Estimates
Atossa Therapeutics Inc (ATOS) is presently subject to a detailed evaluation by 3.0 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.05 and low estimates of -$0.06.
Analysts are recommending an EPS of between -$0.21 and -$0.24 for the fiscal current year, implying an average EPS of -$0.23. EPS for the following year is -$0.27, with 3.0 analysts recommending between -$0.25 and -$0.29.
